NYSE · HIYY
Financial Services · Asset Management
$9.95
Up+$0.45 (+4.52%)
Updated Nov 4, 2026, 7:55 PM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · HIYY
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
HIYY closed at $9.95 after 21 trading sessions, down 14.92% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $9.79 | $10.12 | $9.79 | $9.9547 | 14.55K |
| Nov 2, 2026 | $10.64 | $10.79 | $9.795 | $9.805 | 37.25K |
| Oct 30, 2026 | $10.79 | $10.87 | $10.315 | $10.63 | 25.41K |
| Oct 29, 2026 | $10.98 | $11.20 | $10.905 | $11.06 | 16.78K |
| Oct 28, 2026 | $10.63 | $11.22 | $10.63 | $11.14 | 23.37K |
| Oct 27, 2026 | $10.70 | $10.87 | $10.69 | $10.78 | 19.5K |
| Oct 26, 2026 | $10.58 | $10.70 | $10.51 | $10.60 | 10.69K |
| Oct 23, 2026 | $11.00 | $11.0161 | $10.5501 | $10.6339 | 19.78K |
| Oct 22, 2026 | $10.945 | $11.12 | $10.78 | $10.99 | 50.37K |
| Oct 21, 2026 | $11.22 | $11.41 | $11.18 | $11.21 | 44.47K |
| Oct 20, 2026 | $10.92 | $11.43 | $10.7501 | $11.20 | 23.22K |
| Oct 19, 2026 | $10.88 | $11.1098 | $10.70 | $10.85 | 56.89K |
| Oct 16, 2026 | $11.46 | $11.545 | $10.6101 | $10.87 | 35.25K |
| Oct 15, 2026 | $10.41 | $11.37 | $10.12 | $11.36 | 52.62K |
| Oct 14, 2026 | $11.48 | $11.499 | $10.77 | $10.86 | 69.26K |
| Oct 13, 2026 | $11.80 | $11.80 | $11.24 | $11.58 | 26.35K |
| Oct 12, 2026 | $11.96 | $12.12 | $11.72 | $11.80 | 90.03K |
| Oct 9, 2026 | $11.31 | $12.00 | $11.21 | $11.98 | 66.9K |
| Oct 8, 2026 | $11.50 | $11.57 | $10.91 | $11.16 | 64.66K |
| Oct 7, 2026 | $11.57 | $11.84 | $11.57 | $11.70 | 24.61K |
| Oct 6, 2026 | $11.83 | $11.83 | $11.58 | $11.70 | 32.7K |
The latest Smart Investors Daily articles mentioning HIYY.
Company
Market Activity
Research & News
HIYY research
Company profile and research snapshot.
HIYY aims to generate monthly income while providing exposure to the price returns of the Hims & Hers Health, Inc. stock (HIMS), subject to a cap on potential gains. The fund utilizes a synthetic covered call strategy via standardized exchange-traded and FLEX options, which consists of three elements: i) synthetic long exposure, ii) covered call writing, and iii) US Treasurys for collateral. The synthetic long exposure seeks to replicate the price movements of HIMS by purchasing and selling at-the-money calls and puts that have one- to six-month terms. To generate income, the fund writes call options with an expiration of one month or less and a strike price of approximately 0%-15% above HIMS current share price. This limits participation in potential gains if HIMS shares increase in value. The short put positions fully expose investors to the downside of the stock. Note: the fund does not invest directly in Hims & Hers Health, Inc. stock. Thus, investors are not entitled to any HIMS dividends.
Consensus and target data currently published for this company.
No generated briefing is available yet.
globenewswire.com · Dec 10, 2025
CHICAGO and MILWAUKEE and NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- YieldMax® ETFs today announced distributions for the YieldMax® Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex.
globenewswire.com · Dec 3, 2025
CHICAGO and MILWAUKEE and NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- YieldMax® ETFs today announced distributions for the YieldMax® Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning HIYY.
